A better snapshot of HAIs and antibiotics used to treat them : the Emerging Infections Program Healthcare‐Associated Infections and Antimicrobial Use Prevalence Survey
Corporate Authors:National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion.
Keywords:Anti-Infective Agents/administration & Dosage
Community-Acquired Infections/drug Therapy
Cross Infection/epidemiology/United States
Cross Infection/prevention & Control/United States
Health Facilities/United States
Infection Control/United States
Public Health Surveillance/United States
Description:CDC estimates show that at any given time, 1 in 20 hospital patients has an infection resulting from medical treatment. These infections, known has healthcare‐associated infections (HAIs), can have devastating effects on patients’ physical, mental/emotional, and financial health. In addition, they cost billions of dollars in added expenses to healthcare system. Disturbingly, recent research suggests that a growing number of HAIs are due to pathogens (germs) that are outsmarting the antibiotics typically used to fight them.
Although progress has been made in recent years, gaps still exist in our knowledge about these life‐threatening medical events. In order to develop more advanced strategies to prevent HAIs and preserve antibiotic treatment options, it is essential to answer critical questions about the burden of HAIs and patterns of antibiotic use and resistance in U.S. hospitals.
Supporting Files:No Additional Files
You May Also Like: